Atlantic American Corp is a holding company that operates through its subsidiaries in well-defined specialty markets within the life and health and property and casualty insurance industries.
Last trade$1.30
Day change+$0.12 (+10.17%)
Day range$1.16 – $1.40
Volume91,907
Market cap$24M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$24.07M
Price / earnings
4.28×
Price / book
0.2×
Price / sales
0.11×
EV / sales
0.09×
EV / EBITDA
3.01×
Profitability
Earnings per share
$0.28
Return on assets
1.29%
Return on equity
4.65%
Dividend yield
3.35%
Liquidity and leverage
Debt / equity
0.32×
Current ratio
1.03×
Quick ratio
1.03×
Cash ratio
0.64×
Cash flow
Price / cash flow
0.73×
Price / free cash flow
0.74×
Free cash flow
$32.41M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for AAME, quarterly periods
Line item
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Q3 FY2024 Sep 30, 2024
Q2 FY2024 Jun 30, 2024
Q1 FY2024 Mar 31, 2024
Revenue
$51.27M
$53.76M
$55.29M
$50.13M
$48.9M
$44.52M
$47.67M
$47M
Cost of revenue
$36.51M
$35.47M
$33.65M
$31.91M
$29.59M
$30.76M
$31.81M
$31.93M
Gross profit
$14.76M
$18.29M
$21.64M
$18.21M
$19.31M
$13.76M
$15.86M
$15.07M
Selling, general and administrative
$0
$0
$0
$0
$0
$0
$0
$0
Research and development
—
—
—
—
—
—
—
—
Total operating expenses
$53.68M
$52.21M
$50.3M
$48.32M
$46.22M
$46.1M
$47.65M
$48.65M
Operating income
-$2.41M
$1.55M
$4.99M
$1.81M
$2.68M
-$1.59M
$18K
-$1.65M
Interest expense
-$754K
-$779K
-$773K
-$774K
-$828K
-$869K
-$867K
-$855K
Income before taxes
$1.7M
$769K
$4.22M
$1.04M
$4.18M
-$2.45M
-$849K
-$2.51M
Income taxes
$379K
$192K
$900K
$233K
$897K
-$456K
-$165K
-$508K
Net income
$1.32M
$577K
$3.32M
$802K
$3.29M
-$2M
-$684K
-$2M
Net income attributable to common shareholders
$1.22M
$477K
$3.22M
$703K
$3.19M
-$2.1M
-$784K
-$2.1M
EBITDA
-$2.25M
$2.09M
$4.5M
$2.04M
$2.74M
-$1.54M
-$526K
-$850K
Basic earnings per share
$0.06
$0.02
$0.16
$0.03
$0.16
-$0.10
-$0.04
-$0.10
Diluted earnings per share
$0.06
$0.02
$0.15
$0.03
$0.16
-$0.10
-$0.04
-$0.10
Recent news
Company coverage with links to the original publishers.
Atlantic American Corporation (AAME) received a Nasdaq delisting notice on October 16, 2026, due to failure to file its 2025 Form 10-K and Q1/Q2 2026 Form 10-Q reports by the extended deadline of October 12, 2026. The company filed the 10-K on October 16 and plans to appeal the delisting determination before the Nasdaq Hearings Panel, with a hearing request deadline of October 23, 2026. The company expects to continue trading during the appeal process while working to regain compliance.
Atlantic American Corporation received a Nasdaq notice on August 20, 2026, for non-compliance with filing requirements due to delayed submission of its Form 10-Q for Q2 2026, as well as outstanding filings for the 2025 annual report and Q1 2026 quarterly report. The company has until October 12, 2026 to regain compliance and must submit an updated compliance plan by September 4, 2026. The notice has no immediate effect on the company's Nasdaq listing.
Atlantic American Corporation reported a significant financial turnaround in Q3 2025, with net income of $0.6 million compared to a previous net loss, driven by premium revenue growth across property & casualty and life & health segments.
Atlantic American Corporation reported strong Q2 2025 financial performance, with net income of $3.3 million compared to a net loss in 2024, driven by increased premium revenue and unrealized gains on equity securities across life, health, and property & casualty insurance segments.
Atlantic American Corporation reported a net loss for the year ended December 31, 2024, primarily due to unfavorable loss experience in its property and casualty operations. However, the company saw strong sales in its Medicare supplement business and declared an annual dividend of $0.02 per share.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Apr 9, 2025
$0.02
Apr 23, 2025
recurring
Apr 11, 2024
$0.02
Apr 26, 2024
recurring
Aug 21, 2023
$0.02
Sep 12, 2023
recurring
Apr 12, 2022
$0.02
Apr 27, 2022
recurring
Apr 12, 2021
$0.02
Apr 27, 2021
recurring
Stock splits
Historical share-structure events and their execution dates.